Skip to content
Home/Companies/Biotech/Officinae Bio
OB

Officinae Bio

Biotech·Italy·Exited 2025·Held 4yr

Officinae Bio is a biotech company, headquartered in Italy.

Entry
2021
Hold
4yr
Exit
2025
Est. EV
–

Who owns Officinae Bio?

Officinae Bio was owned by Nucleus Capital through Nucleus Capital I (2021 vintage) from 2021 to 2025, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Nucleus Capital
Investor
Nucleus Capital
Nucleus Capital I · 2021 · VC

Key facts

HQItaly
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025

More from Nucleus Capital I

Other portfolio companies in the same fund.

atmio
Active
SoftwareGermany· 2023
Biographica
Active
BiotechUnited Kingdom· 2023
Biomia
Active
BiotechDenmark· 2023
Brineworks
Active
EnergyNetherlands· 2023
Endolith
Active
IndustrialsUnited States· 2023
Farmless
Active
BiotechNetherlands· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings